.png){kind=spacer}
Nimble has been named one of Canada’s Top 20 Moonshot Ventures of 2026 by the National Angel Capital Organization (NACO.) Each year, the Top 20 are selected following a rigorous national assessment process that reviews companies building critical solutions in high priority sectors like AI, Defence, Cleantech and Healthtech.
Nimble is a precision medicine and data platform company providing unprecedented access to the small intestine with their SIMBA capsule technology. This technology will transform therapeutic approaches to numerous diseases impacting healthcare globally.
“This "moonshot" recognition from NACO validates our ambitious strategy to move beyond the limitations of traditional stool-based diagnostics and access the true epicenter of digestive health.” - Sabina Bruehlmann, Nimble Science CEO and Co-founder
Congratulations Team Nimble!
Read full release here.
